Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Hypoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00857025
What this trial is testing

Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
City of Hope Medical Center 20
Early research (Phase 1)Ended earlyNCT00369551
What this trial is testing

Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Study completedNCT01968941
What this trial is testing

Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer
Ontario Clinical Oncology Group (OCOG) 324
Early research (Phase 1)Study completedNCT00955773
What this trial is testing

The GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

Who this might be right for
Cancer
GlaxoSmithKline 64
Testing effectiveness (Phase 2)Study completedNCT00112346
What this trial is testing

Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eli Lilly and Company 120
Not applicableNot Yet RecruitingNCT07199010
What this trial is testing

Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression

Who this might be right for
Non-small Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 50
Testing effectiveness (Phase 2)Looking for participantsNCT05068232
What this trial is testing

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Who this might be right for
Small-cell Lung CancerExtensive-stage Small-cell Lung CancerLung Cancer
University of Chicago 49
Not applicableStudy completedNCT03073902
What this trial is testing

The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

Who this might be right for
NSCLC
Xinqiao Hospital of Chongqing 80
Testing effectiveness (Phase 2)Looking for participantsNCT07308106
What this trial is testing

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

Who this might be right for
Non-small Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT00553800
What this trial is testing

Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fox Chase Cancer Center 32
Not applicableUnknownNCT04393883
What this trial is testing

A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small-lung-cell Cancer, NSCLCPembrolizumab
Second Affiliated Hospital, Zhejiang University, School of Medicine 216
Large-scale testing (Phase 3)Study completedNCT03469960
What this trial is testing

Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Intergroupe Francophone de Cancerologie Thoracique 265
Not applicableEnded earlyNCT02067858
What this trial is testing

An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System

Who this might be right for
Non Small Cell Lung Cancer4D CT
Steven Burton 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944772
What this trial is testing

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 247
Post-approval studies (Phase 4)Ended earlyNCT00133679
What this trial is testing

Chronic Sildenafil for Severe Diaphragmatic Hernia

Who this might be right for
Hernia, DiaphragmaticHypertension, PulmonaryHypoplasia, Pulmonary
University of California, San Francisco 9
Testing effectiveness (Phase 2)Looking for participantsNCT07583511
What this trial is testing

Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

Who this might be right for
Small-cell Lung Cancer
Sun Yat-sen University 90
Not applicableUnknownNCT05168254
What this trial is testing

Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04340882
What this trial is testing

Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade

Who this might be right for
Metastatic Non-Small Lung Cell CancerRecurrent Non-Small Lung Cell CancerStage IV Lung Cancer AJCC v8+2 more
Emory University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07629960
What this trial is testing

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerColorectal Neoplasms+1 more
Blueprint Medicines Corporation 265
Testing effectiveness (Phase 2)Study completedNCT02951130
What this trial is testing

Milrinone in Congenital Diaphragmatic Hernia

Who this might be right for
Congenital Diaphragmatic HerniaPersistent Pulmonary Hypertension of the NewbornHypoxemic Respiratory Failure+1 more
NICHD Neonatal Research Network 66
Next Page